(WO/1999/033450) PHARMACEUTICAL COMPOSITION CONTAINING SIBUTRAMINE AND ORLISTAT
- Biblio. Data
- Description
- Claims
- National Phase
- Notices
- Documents
| Latest bibliographic data on file with the International Bureau
| |||||||||||||||||||
| |||||||||||||||||||
| IPC: | A61K 31/365 (2006.01) | ||||||||||||||||||
| Applicants: | KNOLL AKTIENGESELLSCHAFT [DE/DE]; D-67061 Ludwigshafen (DE) (All Except US). HEAL, David, John [GB/GB]; (GB) (US Only). JACKSON, Helen, Christine [GB/GB]; (GB) (US Only). | ||||||||||||||||||
| Inventors: | HEAL, David, John; (GB). JACKSON, Helen, Christine; (GB). | ||||||||||||||||||
| Agent: | MILLER, Thomas, Kerr et al.; BASF Aktiengesellschaft, D-67056 Ludwigshafen (DE). | ||||||||||||||||||
| Priority Data: |
| ||||||||||||||||||
| Title: | PHARMACEUTICAL COMPOSITION CONTAINING SIBUTRAMINE AND ORLISTAT | ||||||||||||||||||
| Abstract: | A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of therapeutically effective amount of a compound of formula (I) including enantiomers and pharmaceutically acceptable salts thereof, in which R¿1? and R¿2? are independently H or methyl, and a therapeutically effective amount of a compound of formula (II) wherein the compound of formula (I) and the compound of formula (II) are administered simultaneously, separately or sequentially. | ||||||||||||||||||
| Designated States: |
AL, AU, BG, BR, BY, CA, CN, CZ, GE, HU, ID, IL, JP, KR, KZ, LT, LV, MK, MX, NO, NZ, PL, RO, RU, SG, SI, SK, TR, UA, US. Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE). | ||||||||||||||||||
| Publication Language: | English (EN) |
| Filing Language: | English (EN) |
